-
s The Role of Vasodilator-stimulated Phosphoproteins in the Development of Malignant Tumors
- Source: Current Cancer Drug Targets, Volume 24, Issue 5, May 2024, p. 477 - 489
-
- 01 May 2024
- Previous Article
- Table of Contents
- Next Article
Abstract
Vasodilator-stimulated phosphoprotein (VASP) is an actin-binding protein that includes three structural domains: Enabled/VASP homolog1 (EVH1), EVH2, and proline-rich (PRR). VASP plays an important role in various cellular behaviors related to cytoskeletal regulation. More importantly, VASP plays a key role in the progression of several malignant tumors and is associated with malignant cell proliferation, invasion, and metastasis. Here, we have summarized current studies on the impact of VASP on the development of several malignant tumors and their mechanisms. This study provides a new theoretical basis for clinical molecular diagnosis and molecular targeted therapy.